NCT06798376View on ClinicalTrials.gov

Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 16, 2025

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Gastric Adenocarcinoma
Interventions
DRUG

≤4 cycles of neoadjuvant PD-1 Inhibitors combined with chemotherapy

Any PD-1 inhibitors combined with any chemotherapy regimen given before surgery for no more than 4 cycles

DRUG

≥5 cycles of neoadjuvant PD-1 Inhibitors combined with chemotherapy

Any PD-1 inhibitors combined with any chemotherapy regimen given before surgery for no less than 5 cycles

PROCEDURE

Gastrectomy

Any type of surgical procedure for gastric adenocarcinoma patients in which part or all of the stomach is removed

Trial Locations (1)

100853

RECRUITING

Chinese PLA General Hospital, Beijing

All Listed Sponsors
lead

Chinese PLA General Hospital

OTHER